Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients : An Observational Screening Study
(2021) In Nutrients 13(11).- Abstract
Growth arrest-specific gene 6 protein (Gas6) is avitamin K-dependent tissue bound protein. Gas6 has been shown to promote growth and therapy resistance among different types of cancer as well as thromboembolism. The aim of this prospective screening study: ClinicalTrials.gov; Identifier: NTC3782025, was to evaluate the effects of intravenously administered vitamin K1 on Gas6 and its soluble (s)Axl receptor plasma levels in intensive care patients. Vitamin K1 was intravenously injected in non-warfarin treated patients with prolonged Owren prothrombin time international normalized ratio (PT-INR) > 1.2 and blood samples were retrieved before and 20-28 h after injection. Citrate plasma samples from 52 intensive care patients were... (More)
Growth arrest-specific gene 6 protein (Gas6) is avitamin K-dependent tissue bound protein. Gas6 has been shown to promote growth and therapy resistance among different types of cancer as well as thromboembolism. The aim of this prospective screening study: ClinicalTrials.gov; Identifier: NTC3782025, was to evaluate the effects of intravenously administered vitamin K1 on Gas6 and its soluble (s)Axl receptor plasma levels in intensive care patients. Vitamin K1 was intravenously injected in non-warfarin treated patients with prolonged Owren prothrombin time international normalized ratio (PT-INR) > 1.2 and blood samples were retrieved before and 20-28 h after injection. Citrate plasma samples from 52 intensive care patients were analysed for different vitamin K dependent proteins. There was a significant, but small increase in median Gas6. Only one patient had a large increase in sAxl, but overall, no significant changes in sAxl Gas6 did not correlate to PT-INR, thrombin generation assay, coagulation factors II, VII, IX and X, but to protein S and decarboxylated matrix Gla protein (dp-ucMGP). In conclusion, there was a small increase in Gas6 over 20-28 h. The pathophysiology and clinical importance of this remains to be investigated. To verify a true vitamin K effect, improvement of Gas6 carboxylation defects needs to be studied.
(Less)
- author
- Schott, Ulf
LU
; Augustsson, Cecilia
; Lilover, Luukas
; Ulfsdotter Nilsson, Caroline
LU
; Walther-Sturesson, Louise
LU
and Kander, Thomas
LU
- organization
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nutrients
- volume
- 13
- issue
- 11
- article number
- 4101
- publisher
- MDPI AG
- external identifiers
-
- pmid:34836355
- pmid:34836355
- scopus:85119042469
- ISSN
- 2072-6643
- DOI
- 10.3390/nu13114101
- language
- English
- LU publication?
- yes
- id
- b4373cbe-f382-49b7-bee4-5f8631bcb49f
- date added to LUP
- 2021-11-17 17:41:57
- date last changed
- 2025-04-04 14:25:56
@article{b4373cbe-f382-49b7-bee4-5f8631bcb49f, abstract = {{<p>Growth arrest-specific gene 6 protein (Gas6) is avitamin K-dependent tissue bound protein. Gas6 has been shown to promote growth and therapy resistance among different types of cancer as well as thromboembolism. The aim of this prospective screening study: ClinicalTrials.gov; Identifier: NTC3782025, was to evaluate the effects of intravenously administered vitamin K1 on Gas6 and its soluble (s)Axl receptor plasma levels in intensive care patients. Vitamin K1 was intravenously injected in non-warfarin treated patients with prolonged Owren prothrombin time international normalized ratio (PT-INR) > 1.2 and blood samples were retrieved before and 20-28 h after injection. Citrate plasma samples from 52 intensive care patients were analysed for different vitamin K dependent proteins. There was a significant, but small increase in median Gas6. Only one patient had a large increase in sAxl, but overall, no significant changes in sAxl Gas6 did not correlate to PT-INR, thrombin generation assay, coagulation factors II, VII, IX and X, but to protein S and decarboxylated matrix Gla protein (dp-ucMGP). In conclusion, there was a small increase in Gas6 over 20-28 h. The pathophysiology and clinical importance of this remains to be investigated. To verify a true vitamin K effect, improvement of Gas6 carboxylation defects needs to be studied.</p>}}, author = {{Schott, Ulf and Augustsson, Cecilia and Lilover, Luukas and Ulfsdotter Nilsson, Caroline and Walther-Sturesson, Louise and Kander, Thomas}}, issn = {{2072-6643}}, language = {{eng}}, number = {{11}}, publisher = {{MDPI AG}}, series = {{Nutrients}}, title = {{Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients : An Observational Screening Study}}, url = {{http://dx.doi.org/10.3390/nu13114101}}, doi = {{10.3390/nu13114101}}, volume = {{13}}, year = {{2021}}, }